Inside Precision Medicine January 3, 2024
SimBioSys, which specializes in spatial biophysics and artificial intelligence (AI), has recently entered into a strategic collaboration with Mayo Clinic to advance digital precision medicine solutions for breast cancer patients. The collaboration will develop cloud-based clinical software tools that will guide the decision-making process for early-stage breast cancer patients, covering personalized surgical planning, treatment strategies, drug selection, and risk assessment.
According to the two parties, the collaboration intends to address the evolving landscape of breast cancer treatment by tailoring care to individual patients, optimizing therapies, and improving quality of life without compromising outcomes.
The collaboration includes Mayo Clinic physicians Judy C. Boughey, M.D., and Matthew Goetz, M.D., who are actively contributing to SimBioSys’s clinical advisory team. Their expertise in breast...
Today's Sponsors
Today's Sponsor